אלוריל 300

Kraj: Izrael

Język: hebrajski

Źródło: Ministry of Health

Składnik aktywny:

ALLOPURINOL

Dostępny od:

DEXCEL LTD, ISRAEL

Kod ATC:

M04AA01

Forma farmaceutyczna:

טבליה

Skład:

ALLOPURINOL 300 MG

Droga podania:

פומי

Typ recepty:

מרשם נדרש

Wyprodukowano przez:

DEXCEL LTD, ISRAEL

Grupa terapeutyczna:

ALLOPURINOL

Dziedzina terapeutyczna:

ALLOPURINOL

Wskazania:

Management of patients with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis and/or nephropathy). Management of patients with leukemia, lymphoma, and malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels. Management of patients with recurrent calcium oxalate calculi whose daily uric acid excretion exceeds 800 mg/day in male patients and 750 mg/day in female patients. Therapy in such patients should be carefully assessed initially and reassessed periodically to determine in each case that treatment is beneficial and that the benefits outweigh the risks.

Data autoryzacji:

2014-02-28